• Nestle SA to Buy Pfizer Inc. (PFE)'s Infant Nutrition Unit for $11.9 Billion More...

• AstraZeneca PLC (AZN) to Acquire Ardea Biosciences, Inc. for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout More...

• Nabi Biopharmaceuticals (NABI) Merges With Biota Holdings Limited (BTA.AX) to Create a $250 Million Group; Biota to Move to the US More...

• Roche (RHHBY) Starts Talking to Illumina, Inc. (ILMN) Rivals More...

• OLIGOMERIX Completes $2 Million Series A Financing More...

• OrbiMed Launches $222 Million Fund Focused on Israel Life Sciences More...

• Merck & Co., Inc. (MRK) Invests $150 Million In R&D at Jamia Millia Islamic University More...

• Israeli High Tech Firms Raise $483 Million in Q1 from VCs More...

• AMAG Pharmaceuticals, Inc. (AMAG) Gets Initial EU Nod, Potentially Bagging a $30 Million Milestone Payment From Takeda Pharmaceutical Co. Ltd. (TKDG.DE) More...

• Biovest International, Inc. and US Army Enter into Collaborative Agreement to Develop Novel Bioreactor Systems as Platform Technology for Production of Anti-Viral Vaccines and Drugs More...

• Johnson & Johnson (JNJ) Open to Expanding Hepatitis C Cooperation WithVertex Pharmaceuticals (MA) (VRTX) More...

• Pressure BioSciences, Inc. (BBII) and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services More...

• Ezose Sciences, Inc. and Hirosaki University to Collaborate in Glycomics Research to Find New Cancer Biomarkers More...

• Kolltan Pharmaceuticals Inc. Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer More...

• Quintiles Transnational Corp. Names Tom Pike CEO More...

• PAREXEL International (PRXL) Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award More...

• Alnylam Pharmaceuticals (ALNY) Elects Dr. Dennis Ausiello to its Board of Directors and Scientific Advisory Board More...

• Compugen Ltd. (CGEN) First Quarter 2012 Conference Call Scheduled for Tuesday, May 1, 2012 at 10:00 AM EST More...

• Association of Clinical Research Organizations (ACRO) Testifies Before FDA on Clinical Trial Modernization More...

• Novartis AG (NVS) Plans $550 Million Manufacturing Plant in Switzerland More...

• Ultragenyx Relocates Company Headquarters to Support Operational Expansion More...

• QUMAS Opens New Asian Office in Singapore More...

• FDA Pushes Back Bowel Drug Review: Ironwood Pharmaceuticals, Forest Laboratories, Inc. (FRX) More...

• AMAG Pharmaceuticals, Inc. (AMAG) Gets Initial EU Nod, Potentially Bagging a $30 Million Milestone Payment From Takeda Pharmaceutical Co. Ltd. (TKDG.DE) More...

• AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY) Say FORXIGA Gets Positive CHMP Opinion in EU More...

• Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Receives Further Opinion on Glybera® Marketing Authorization Application More...

• Achillion Pharmaceuticals, Inc. Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C More...

• PolyMedix Inc. (PYMX.OB) Announces Positive Results From Phase 2 Clinical Trial With PMX-30063 First-in-Class Defensin-Mimetic Antibiotic More...

• Celsion Corporation (CLN) Announces Data Monitoring Committee Unanimously Recommends Continuation of Phase III HEAT Study of ThermoDox® in Primary Liver Cancer More...

• Keryx Biopharmaceuticals (KERX) Announces Positive Top-Line Results from Phase 3 Study of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco, Inc. and Torii Pharmaceutical Co. More...

• Medgenics, Inc. Files for U.S. Orphan Drug Designation for INFRADURE for the Treatment of Hepatitis D More...

• Depression Linked to Higher Odds for Poor Leg Circulation, University of California, San Francisco (UCSF) Study More...

• "Ice Cream Headaches" Might Offer Clues to Migraines, Harvard Medical School Study More...

• Soda Elevates and Coffee Lowers Stroke Risk, Harvard University andCleveland Clinic's Wellness Institute Study More...

• Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned, Center for Clinical Intervention Research Study More...

• BioTime (BTX) Demonstrates Efficient Method for the Manufacture of Cartilage-Producing Cells from Human Embryonic Stem Cells More...

• Regulus Therapeutics, Inc. Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate More...

• Spectrum Pharmaceuticals, Inc. (SPPI) Expands Manufacturing Capacity and Builds Inventory Reserves for FUSILEV® More...